wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38957093-E893863C-D5C0-4A29-8111-233EB922F706
Q38957093-E893863C-D5C0-4A29-8111-233EB922F706
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38957093-E893863C-D5C0-4A29-8111-233EB922F706
Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma.
P2860
Q38957093-E893863C-D5C0-4A29-8111-233EB922F706
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38957093-E893863C-D5C0-4A29-8111-233EB922F706
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
849f69a4ec474972efc158833ee0ef8539cc5c02
P2860
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.